Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

研究方向

Apoptosis 相关产品(2721)

  • GC60949 structure
    GC60949Isolongifolene
    CAS: 1135-66-6
    纯度: >98.00%

    Isolongifolene((-)-Isolongifolene)是一种从Murrayakoenigii中分离的三环倍半萜烯。Isolongifolene通过调节P13K/AKT/GSK-3β信号通路来减轻鱼藤酮诱导的氧化应激,线粒体功能障碍和细胞凋亡。Isolongifolene具有抗氧化,抗炎,抗癌和神经保护的特性。

  • GC60962 structure
    GC60962Kauran-16,17-diol
    CAS: 16836-31-0

    Kauran-16,17-diol(ent-Kauran-16β,17-diol)是一个天然的二萜化合物,具有抗肿瘤诱导凋亡的活性。其抑制LPS诱导的RAW264.7细胞产生NO的IC50值为17μM。

  • GC60969 structure
    GC60969KRAS inhibitor-9
    CAS: 300809-71-6
    纯度: >99.50%

    KRASinhibitor-9是有效的KRAS抑制剂(Kd=92μM),阻止GTP-KRAS的形成和KRAS下游激活。KRASinhibitor-9以中等的结合亲和力与KRASG12D,KRASG12C和KRASQ61H蛋白结合。KRASinhibitor-9导致G2/M细胞周期停滞并诱导凋亡(apoptosis)。KRASinhibitor-9选择性抑制具有KRAS突变的NSCLC细胞的增殖,但不抑制正常肺细胞的增殖。KRASinhibitor-9

  • GC60997 structure
    GC60997Lixisenatide acetate
    CAS: 1997361-87-1
    纯度: >98.50%

    Lixisenatideacetate是胰高血糖素样肽1受体(GLP-1R)的激动剂,可用于2型糖尿病的研究。

  • GC61021 structure
    GC61021Malachite green oxalate
    CAS: 2437-29-8
    纯度: >98.00%

    Malachite green (Aniline green, Basic green 4, Diamond green B, Victoria green B) is a synthetic dyestuff and antimicrobial with potential carcinogenicity.

  • GC61041 structure
    GC61041Mepazine hydrochloride
    CAS: 2975-36-2
    纯度: >98.00%

    Mepazinehydrochloride(Pecazinehydrochloride)是一种有效的选择性MALT1蛋白酶抑制剂。Mepazinehydrochloride抑制全长GSTMALT1和GSTMALT1325-760段的IC50分别为0.83和0.42μM。Mepazinehydrochloride通过增强细胞凋亡(apoptosis)来影响ABC-DLBCL细胞的生存能力。

  • GC61047 structure
    GC61047Methotrexate disodium
    CAS: 7413-34-5
    纯度: >98.00%

    Methotrexate sodium, an inhibitor of tetrahydrofolate dehydrogenase, is an antineoplastic antimetabolite with immunosuppressant properties.

  • GC61079 structure
    GC61079Monensin
    CAS: 17090-79-8
    纯度: >98.00%

    莫能菌素(蛋白质转运抑制剂)是一种离子载体,可破坏高尔基体,抑制细胞内蛋白质转运。

  • GC61093 structure
    GC61093MSAB
    CAS: 173436-66-3
    纯度: >99.50% / >99.00%

    MSAB(methyl 3-{[(4-methylphenyl)sulfonyl]amino}benzoate)是一种选择性Wnt/β-catenin信号抑制剂,与β-catenin结合并促进其降解,其EC 50 为0.583μM。

  • GC61096 structure
    GC61096MSN-125
    CAS: 1592908-16-1
    纯度: >98.50%

    MSN-125是一种Bax和Bak寡聚化的抑制剂,其IC 50 为4μM。

  • GC61141 structure
    GC61141NSC 15364
    CAS: 4550-72-5
    纯度: >98.00%

    NSC15364是一种VDAC1寡聚化和细胞凋亡(apoptosis)抑制剂。

  • GC61142 structure
    GC61142NSC745885
    CAS: 4219-52-7
    纯度: >98.00%

    NSC745885是一种有效的抗肿瘤(anti-tumor)试剂,对多种癌细胞株有选择性毒性,但对正常细胞没有毒性。NSC745885是一种有效的EZH2的下调因子通过蛋白酶体降解途径。NSC745885为晚期膀胱癌和口腔鳞癌的研究提供了可能性。

  • GC61179 structure
    GC61179Phenazine methylsulfate
    CAS: 299-11-6
    纯度: >98.00%

    A free radical generator

  • GC61183 structure
    GC61183Physalin B
    CAS: 23133-56-4

    PhysalinB是Capegooseberry中主要的甾体活性成分之一,通过调节p53依赖的凋亡途径,诱导乳腺癌细胞周期阻滞和诱导凋亡(apoptosis)。PhysalinB抑制人结肠癌细胞泛素-蛋白酶体通路并诱导不完全自噬反应。

  • GC61184 structure
    GC61184Physalin F
    CAS: 57423-71-9

    PhysalinF是一种具有强烈抗炎和免疫调节作用的分泌型甾体。PhysalinF诱导人外周血单个核细胞凋亡,降低人T淋巴细胞1型病毒(HTLV-1)感染后的自发增殖和细胞因子的产生。

  • GC61203 structure
    GC61203Ponicidin
    CAS: 52617-37-5
    纯度: >99.50%

    Ponicidin(RubescensineB)是源于冬凌草的二萜,具有免疫调节、抗炎、抗病毒和抗癌作用。Ponicidin(RubescensineB)可诱导胃癌细胞凋亡(apoptosis),降低JAK2和STAT3的磷酸化水平,单对其蛋白水平无作用。

  • GC61215 structure
    GC61215PROTAC RIPK degrader-6
    CAS: 2089205-64-9
    纯度: >99.00%

    PROTACRIPKdegrader-6(example1)是一种PROTAC类的有效RIPK降解剂。

  • GC61224 structure
    GC61224Pyrazoloacridine
    CAS: 99009-20-8
    纯度: >98.00%

    Pyrazoloacridine(NSC366140)具有抗癌活性,抑制拓扑异构酶1和2的活性(topoisomerases1and2)。Pyrazoloacridine(NSC366140)对K562髓系白血病细胞中的IC50值为1.25μM(24h)。

  • GC61227 structure
    GC61227Quercetin D5
    CAS: 263711-78-0
    纯度: >99.00%

    Quercetin D5是天然产物槲皮素(Quercetin)的氘代同位素内标,其化学结构通常在槲皮素的A环上由5个D原子取代了原有的5个H原子。

  • GC61229 structure
    GC61229Quinacrine dihydrochloride
    CAS: 69-05-6
    纯度: >99.00%

    Quinacrine 2HCl(Quinacrine dihydrochloride) is a lipophilic cationic drug with multiple actions that is commonly used as an anti-protozoal agent. Quinacrine is an effective phospholipase A2 inhibitor.

  • GC61252 structure
    GC61252Rotundifuran
    CAS: 50656-65-0

    Rotundifuran是一种从Vitexrotundifolia中分离的拉丹烷型二萜。Rotundifuran能够抑制人骨髓白血病细胞的细胞周期进程并诱导细胞凋亡。

  • GC61264 structure
    GC61264Sandacanol
    CAS: 28219-61-6

    Sandacanol是嗅觉受体(OR10H1)的特异性激动剂。Sandacanol诱导膀胱癌细胞发生细胞周期停滞和凋亡(apoptosis)。

  • GC61314 structure
    GC61314Taltobulin hydrochloride
    纯度: >99.00%

    Taltobulinhydrochloride(HTI-286hydrochloride)是一种合成的三肽半胱氨酸类似物,Taltobulin是一种有效的抗微管剂(antimicrotubule),可在体内外规避P-糖蛋白介导的耐药性。Taltobulinhydrochloride抑制纯化的微管蛋白聚合,破坏细胞中的微管组织,并诱导有丝分裂停滞以及凋亡(apoptosis)。

  • GC61338 structure
    GC61338Toralactone
    CAS: 41743-74-2

    Toralactone可从Cassiaobtusifolia中分离得到,通过Nrf2依赖的抗氧化机制介导肝保护。